$1B Medicare Advantage fraud case against UnitedHealth can proceed

The U.S. Department of Justice (DOJ) can move forward with a lawsuit alleging UnitedHealth Group wrongly collected more than $1 billion through Medicare Advantage by finding conditions to increase a patient’s risk adjustment payment from CMS.

According to Reuters, some of the DOJ’s claims related to false attestation of the data were dismissed, but unlike a separate Medicare Advantage lawsuit against UnitedHealth, a federal judge didn’t dismiss the entire case.

This case was first brought to court by former UnitedHealth executive Benjamin Poehling, who said he monitored the data-mining projects looking for additional diagnoses which could boost MA payments to UnitedHealth. He further claimed his team was given bonuses for hitting revenue targets—not improving patient outcomes or identifying conditions which wouldn’t increase risk scores or reimbursement. If the suit is successful, Poehling would be entitled to part of the money recovered from UnitedHealth.

The insurer has continued to deny the allegations.

“We reject the government’s remaining claims and will continue to aggressively contest them,” a UnitedHealth Group spokesperson said in a statement to the Minneapolis Star-Tribune.

More of the lawsuit could be dismissed, however. The ruling by U.S. District Judge Michael Fitzgerald said three of the six claims would be removed from the lawsuit unless the DOJ amends its complaints by Feb. 26.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”